MELI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MercadoLibre Inc (MELI) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company shows long-term growth potential and has been making significant investments in logistics and financial services, the current technical indicators, mixed analyst sentiment, and recent financial performance suggest a cautious approach. The stock's pre-market price is stable, and there are no strong proprietary trading signals to suggest immediate action.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 36.285, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 1619.431), but there is no clear breakout signal. Short-term stock trend analysis suggests a potential decline of -0.21% in the next day, -0.64% in the next week, and -3.77% in the next month.
MercadoLibre announced a $10.9 billion investment in Brazil by 2026, focusing on logistics and financial services expansion, which could drive long-term growth.
Meta's expansion of affiliate partnerships, including MercadoLibre, could enhance e-commerce capabilities and drive user engagement.
Analysts have recently downgraded the stock or lowered price targets due to concerns over competition and higher investment levels impacting margins.
Financial performance in Q4 2025 showed a decline in net income (-12.52% YoY) and EPS (-12.46% YoY), with gross margins also dropping (-4.78% YoY).
Stock trend analysis suggests short-term weakness, with a high probability of declines in the next day, week, and month.
In Q4 2025, MercadoLibre's revenue increased by 44.56% YoY to $8.76 billion, showcasing strong top-line growth. However, net income declined by 12.52% YoY to $559 million, and EPS dropped by 12.46% YoY to $11.03. Gross margin also decreased to 43.2%, down 4.78% YoY, reflecting higher investment levels impacting profitability.
Analysts have mixed ratings on MELI. Recent downgrades include JPMorgan lowering its rating to Neutral and reducing the price target to $2,100 due to competitive pressures and higher investment levels. However, firms like BTIG and Morgan Stanley maintain Buy or Overweight ratings, citing long-term growth potential despite near-term margin pressures. Price targets have been revised downward across the board, reflecting cautious sentiment.
